Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Dulaglutide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus

Singapore, April 30 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Dulaglutide on Re... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 30 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Clinical Trial: A Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugate) as a Monotherapy in Adult Patients with Selected Advanced or Metastatic CLDN1+ Solid Tumors

Singapore, April 30 -- The Health Sciences Authority received information related to the study titled 'A Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugat... Read More


Norvic Hospital moves ahead with book building IPO, seeks bids from institutional investors

Nepal, April 30 -- Norvic International Hospital has moved forward with the process of issuing an Initial Public Offering (IPO) through the book building method. The company has invited institutional... Read More


Dr. Rajeshwar Singh proposes Nari shakti industrial promotion policy for women-led industrial growth model

Lucknow, April 30 -- On the day when Uttar Pradesh assembly holding discussions on the women reservation Bill, BJP MLA from Lucknow Rajeshwar Singh, has suggested implementing the "Chief Minister Nari... Read More


No HeadLine Found

Saibal GuptaKolkata, April 30 -- In an unprecedented polling surge, 22 constituencies recorded polling percentages above 95 percent in the second phase of the West Bengal Assembly elections, with Mina... Read More


किशोरी के घर पहुंची टीम, इंजेक्शन के बारे में ली जानकारी

महाराजगंज, अप्रैल 30 -- महराजगंज, हिन्दुस्तान टीम। एसीएमओ प्राइवेट हास्पिटल नोडल अधिकारी डॉ. वीरेंद्र आर्या के नेतृत्व में टीम कटहरा खास टोला उसरहवा निवासी मृत किशोरी के घर पहुंची। परिजनों से इंजेक्शन... Read More


Midland Bank PLC, Sonic (Bangladesh) Ltd sign MoU for cash management services

Dhaka, April 30 -- Midland Bank PLC has signed a Memorandum of Understanding (MoU) with Sonic (Bangladesh) Ltd to provide advanced cash management solutions for efficient financial operations. The Mo... Read More